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AMIXL1-eGFP reporter human embryonic stem cell (hESC; clones 4–
21) line was generated using TALEN-based genome targeting of WA09
(H9, NIH registration number 0062) hESCs replacing the stop codon of
endogenous MIXL1 with a 2A-eGFP cassette, thus, creating a MIXL1-
2A-eGFP allele, (Fig. 1A).
Correct integrationwas conﬁmedby sequencing of PRC products ob-
tained from genomic DNA using speciﬁc primers (see Table 1) aswell as
Southern blot analysis (Fig. 1B).
Prior to deciding to use WA09 to create the MIXL1 reporter line, we
sent the line for G-banded karyotype analysis. Initial results showed a
normal karyotype of parental WA09 (Fig. 1C, left panel). The reporter
was created and then both the reporter and the parental line were re-
sent for karyotype analysis. However, upon high resolution chromo-
somal analysis of the MIXL1-eGFP hESC line as well as the parental
WA09 hESCs, a clonal abnormality, an interstitial duplication, resulting
in partial trisomy of the long (q) arm of chromosome 1 was identiﬁed
in both lines, which is a recurrent acquired abnormality in human plu-
ripotent stem cell cultures (Na et al. 2014) (Fig. 1C, right panels). In ad-
dition, the long (q) arm of chromosome 1 is partially duplicated and
translocated to the end of the short arm of chromosome X in the
MIXL1-eGFP hESC line (10 of 20 cells examined). Seven of 20 MIXL1-
eGFP hESCs were found to have no abnormality. Short tandem repeat
analysis conﬁrmed the WA09 hESC origin of the generated MIXL1-
eGFP reporter hESC line (Fig. 1D).
To conﬁrm the pluripotency of the MIXL1-eGFP hESCs, the expres-
sion of several pluripotency markers was analyzed by quantitative
real-timePCRaswell as immunocytochemsitry. Endogenous expressionthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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time PCR (Fig. 1C). Protein expression of OCT4, NANOG, and SOX2 was
assayed by immunocytochemsitry (Fig. 1D).Three germ-layer differentiation ability was demonstrated by spon-
taneous in vitro differentiation of embryoid bodies with subsequent
replating and immunocytochemical detection of smooth muscle actin
Table 1
Primer sets used.
Gene or locus 5′ primer sequence [5′→ 3′] 3′ primer sequence [5′→ 3′]
Ampliﬁcation of homologous arms
MIXL1 upstream arm GACCTGCAGGCATGAGCAAAATACCTCa GCGCTAGCAAAGTTACCAAAGGCAGAAAAGA
MIXL1 downstream arm GAGGCGCGCCAATTCGGGATAAGCT GAGGCCGGCCGTGCCCAGCTAAGTTTTA
Targeted integration
MIXL1 locus GGTAAGGAGAAGCCTGCCTTT AAGTCGTGCTGCCTTCATGTGa [PMID: 21738127]
Southern blot probe
GFP probe ACGTAAACGGCCACAAGTTC CTGGGTGCTCAGGTAGTGGT




hMIXL1 (endogenous) CTGTGCTCCTGGAACTGAAACGAAAT ACCTTGGGAGCTAGAGTCAGAGATG
hβ-ACTIN TTTTTGGCTTGACTCAGGATTT GCAAGGGACTTCCTGTAACAAC
a Hockemeyer at al. (2011). Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731–734.
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III tubulin (TUJI) for ectoderm (Fig. 1G).
Correlation of eGFP expression with endogenousMIXL1 expression
was conﬁrmed by ﬂow cytometry and real-time PCR during speciﬁc in
vitro differentiation to the 3-germ layers (mesoderm, endoderm and
neuroectoderm) (Fig. 1H & I). Expression was dynamic and restricted
to speciﬁc times during differentiation that correlate with the emer-
gence ofmesodermal or endodermal precursors. Immunocytochemistry
corroborated the ﬂow cytometry and PCR results (Fig. 1J and data not
shown).
2. Materials and methods
2.1. Maintenance of human embryonic stem cells
Human ESCs cells were generally maintained on an irradiated layer
of mouse embryonic ﬁbroblasts (MEFs) in hESC medium consisting of
DMEM/F12 (Invitrogen) supplemented with 20% KnockOut Serum Re-
placement (Invitrogen), 2 mM L-Glutamine (Invitrogen), 100 units/mL
Penicillin and 100 μg/mL of Streptomycin (Invitrogen), 1× Non-Essen-
tial Amino Acids, 0.1 mM 2-mercaptoethanol and 20 ng/mL bFGF
(R&D Systems). For feeder-free culture, cells were grown on Matrigel
(Corning)-coated surfaces in mTeSR1 medium (StemCell Technologies)
supplemented with 2 mM L-Glutamine and 100 units/mL Penicillin and
100 μg/mL of Streptomycin.
2.2. Generation of a MIXL1-eGFP reporter H9 human embryonic stem cell
line using TALEN-based genome engineering
Homologous armswere ampliﬁed using genomic DNA isolated from
WA09 hESCs and primers to amplify the upstream homologous arm or
the downstream homologous arm, respectively (see Table 1 for primer
sequences). PCR products were run on a 1% agarose gel, gelpuriﬁed
and digested with SbfI and NheI (upstream homologous arm), and
AscI and FseI (downstream homologous arm), respectively, and ligatedFig. 1. Generation and characterization of engineered human MIXL1-2A-eGFP reporter embry
plasmid carrying 2A-eGFP and a ﬂoxed PGK promoter-driven puromycin resistance gene ca
integration (left). Southern blot analysis of NheI digested genomic DNA demonstrated a single
additional random integration (asterisk). (C) G-band karyotype analysis of parental WA0
engineered MIXL1-eGFP reporter hESC line (right, lower panel, high resolution). (FD Sho
Quantitative real-time PCR analysis of the pluripotency factors NANOG, OCT4 and SOX2 i
normalized to β-ACTIN and represented as mean ± SD (n= 3) relative to WA09. (F) Immuno
reporter hESC line. Red, NANOG, OCT4 or SOX2, respectively; blue, DAPI (nucleus); sca
immunocytochemistry on differentiatedMIXL1-eGFP reporter hESCs. Purple, TUJ1 for neuroec
stain the nucleus. Scale bar, 75 μm. (H) Flow cytometry analysis of eGFP expression at indicat
mRNA expression by quantitative real-time PCR at indicated time points after directed differ
mean ± SD (n= 3) relative to the undifferentiated, pluripotent state (D0). (J) PAX6 expressio
(nucleus); scale bar, 250 μm.into the OCT4-2AeGFP-PGK-Puro vector (Addgene) replacing the OCT4
homologous arms.
TALENs targeting 5′-TTCTGCCTTTGGTAACTT-3′ upstream of the
MIXL1 Stop codon, and 5′-TCAGAGCTTATCCCGAAT-3′ downstream of
the MIXL1 Stop codon, respectively, were assembled using the Joung
Lab REAL Assembly TALEN kit (Addgene) according to protocol
(Sander et al. 2011).
To generate the MIXL1-eGFP reporter line, 107 WA09 hESCs were
mixed with 40 μg of MIXL1-2A-eGFP-PGK-Puro donor plasmid and
5 μg of each TALEN encoding plasmid in 800 μL of PBS in 0.4 cmcuvettes.
Electroporation was performed at 250 V and 500 μF using a GenePulser
Xcell system (Bio-Rad). Cells were plated on irradiated DR4 MEFs and
selected with 0.5 μg/mL puromycin starting on day 5 after electropora-
tion. Resistant colonies were picked and expanded.
2.3. Southern blot analysis
Tenmicrograms of genomic DNA frompotentialMIXL1-eGFP report-
er cloneswere digestedwithNheI (NEB) overnight at 37 °C and run on a
1% agarose gel. The DNA was transferred from the gel to a positively
charge nylon membrane using a standard protocol. The DIG DNA Label-
ing and Detection Kit (Roche) in combination with a GFP fragment (see
Table 1 for primer sequences)wasused for probe labeling, hybridization
and signal detection according to the manufacturer's instruction.
2.4. PCR and quantitative real-time PCR
PCR on ~100 ng of genomic DNA was performed using Fusionﬂash
High Fidelity PCR Master Mix (Finnzymes) at 98 °C for 1 min, 35 cycles
of 98 °C for 1 min – 55 °C and 57 °C, respectively, for 5 s and 72 °C for
30 s, followed by a ﬁnal extension at 72 °C for 1 min in a Veriti 96-
well Thermal Cycler (Applied Biosystems). Quantitative real-time PCR
on cDNA prepared from 500 ng RNA isolated from cells using TRIzol
was performed using FastSybR GreenMaster Mix (Applied Biosystems)
according to themanufacturer's instruction in a Lightcycler 480 (Roche)onic stem cell. (A) Schematic of TALEN-based targeting of theMIXL1 locus with a donor
ssette. (B) PCR based integration analysis produced a band of ~1 kb, indicating correct
GFP insert (arrow) in the correctly targeted clone 4–21 (right), while clone 3–16 had an
9 hESCs used for gene targeting (left, low resolution; right, high resolution) and the
rt tandem repeat analysis of the MIXL1-eGFP line proved its WA09 hESC origin. (E)
n the targeted MIXL1-eGFP reporter hESC line and the original WA09 cells. Data are
cytochemical analysis of NANOG, OCT4 and SOX2 protein expression in theMIXL1-eGFP
le bar, 75 μm. (G) MIXL1-eGFP reporter hESCs are pluripotent as demonstrated by
toderm; green, AFP for endoderm and red, SMA for mesoderm. DAPI (blue) was used to
ed time points after directed differentiation to the speciﬁc germ layer. (I) Relative MIXL1
entiation to the speciﬁc germ layer. Data are normalized to β-ACTIN and represented as
n in neuronal rosettes at day 10 of neuroectoderm differentiation. Red, PAX6; blue, DAPI
96 V. Alexeeva et al. / Stem Cell Research 17 (2016) 93–96at 95 °C for 1min (initial denaturing step), followed by 40 cycles of 95 °C
for 3 s and 60 °C for 30 s. Data were normalized to β-ACTIN. Primers are
listed in Table 1.
2.5. Karyotype analysis and cell identity by short tandem repeat analysis
Chromosomal G-banding karyotype analysis was performed at the
Cytogenetics Laboratory at Mount Sinai. High resolution karyotyping
as well as short tandem repeat analysis for parental cell authentication
was performed by the WiCell Research Institute (Madison, WI).
2.6. In vitro differentiation of MIXL1-eGFP reporter H9 embryonic stem cell
line
For general 3-germ layer differentiation, MIXL1-eGFP cells grown
feeder-free on Matrigel in mTeSR1 media (StemCell Technologies) to
60–70% conﬂuence were dissociated with Accutase and replated into
low attachment plates in DMEM/20% FBS media to enable embryoid
body (EB) formation and random differentiation. On day 8 of differenti-
ation, EBs were collected, replated onto Matrigel-coated 48-well plates
and grown for an additional 14 days in DMEM/20% FBS with feeding
every other day, and then processed for immunocytochemistry.
For mesoderm differentiation (Kennedy et al. 2012), MIXL1-eGFP
cells, grown feeder-free on Matrigel in mTESR media (StemCell Tech-
nologies) to 60–70% conﬂuency were collected with 0.5 mM EDTA in
PBS, resuspended in StemSpan medium (Stemcell Technologies) sup-
plemented with 2 mM L-Glutamine, 50 μg/mL ascorbic acid,
4 × 10−4 M monothioglycerol (StemSpan Complete), and containing
10 ng/mL BMP4 and 150 μg/mL Transferrin, and replated into low at-
tachment plates for EBs formation (day 0). On day 1, medium was
changed to StemSpan complete with 10 ng/mL BMP4 and 5 ng/mL
bFGF. On day 2, medium was changed to StemSpan Complete supple-
mented with 10 ng/mL BMP4 and 1 ng/mL ActivinA. On day 4 medium
was changed to StemSpan Complete supplemented with 5 ng/mL bFGF,
15 μg/mL VEGF, 150 ng/mL DKK-1, 10 ng/mL IL-6, 5 ng/mL IL-11 and
25 ng/mL IGF-1. Differentiation was continued until day 5. Cells were
harvested daily for PCR and FACS analyses.
For endoderm differentiation, MIXL1-eGFP cells, grown feeder-free
on Matrigel in mTESR media (StemCell Technologies) to 60–70%
conﬂuency were collected using Accutase and replated onto Matrigel-
coated 24-well plates inmTESRmedia (D0). After 24 h,mediumwas re-
placed with STEMdiff Deﬁnitive Endoderm Basal Medium supplement-
ed with Endoderm Supplement A and Endoderm Supplement B (1:100
dilution; StemCell Technologies). On Day 2, medium was changed to
STEMdiff Deﬁnitive Endoderm Basal Medium supplemented with De-
ﬁnitive Endoderm Supplement B. On day 3 and day 4, medium was
refreshed as on day 2. Differentiation was continued until day 5. Cells
were harvested daily for PCR and FACS analysis.
For neuroectoderm differentiation,MIXL1-eGFP cells, grown feeder-
free on Matrigel in mTESR media (StemCell Technologies) to 60–70%
conﬂuency were collected with 0.5 mM EDTA in PBS, and resuspended
in STEMdiff Neural Induction medium (StemCell Technologies) and
cultured in low attachment plates to enable EBs formation. On day
8 day, EBs were replated onto Matrigel-coated 12-well plates in
STEMdiff Neural Induction medium for 2 days until neural rosettes
were observed.
2.7. Immunocytochemistry
MIXL1-eGFP hESCs or its differentiated progenitors were ﬁxed with
4% Paraformaldehyde in PBS for 15min at RT, washedwith PBS, perme-
abilizedwith 0.2% Triton X-100 for 10min at RT and rewashedwith PBS.
Cells were blocked using a 0.05% saponin solution (PBS, 1% Glucose,0.02% sodium azide, 5 mM HEPES, 0.05% Saponin) containing 10% of
the serum from the animal inwhich the secondary antibodieswere gen-
erated in.
For pluripotency marker detection, cells were incubated with the
following primary antibodies at a 1:200 dilution overnight at 4 °C: rab-
bit-polyclonal anti-Oct4 (Stemgent), goat-polyclonal anti-Sox2 (Santa
Cruz Biotechnologies), goat-polyclonal anti-Nanog (R&D Systems).
Cells were washed three times in 0.05% saponin solution for 15 min
each. Cells were then incubated with donkey anti-goat Alexa Fluor
647 or donkey anti-rabbit Alexa Fluor 647 (Life Technologies) second-
ary antibody, respectively, at a 1:500 concentration for 60 min. Cells
were washed 3 times in 0.05% saponin solution to remove the unbound
secondary antibody. DAPI at 1:1000 dilution was added for the last
wash.
For detection of PAX6, cells were incubated with rabbit-polyclonal
anti-Pax6 (BioLegend), followed by donkey anti-rabbit Alexa Fluor 555.
For 3-germ layer identiﬁcation, ﬁxed cells were processed using the
3-Germ Layer Immunocytochemistry Kit (Life Technologies) according
to the manufacturer's instruction. Brieﬂy, cells were incubated with
the blocking solution for 1 h at RT, then incubated with primary anti-
bodies (rabbit anti-TUJI (1:250), mouse IgG1 anti-AFP (1:250), and
mouse IgG2 anti-SMA (1:100)) overnight at 4 °C. The next day, cells
were washed 3 times for 15 min in 0.05% saponin solution followed
by incubation with secondary antibodies (Alexa Fluor 647 donkey
anti-rabbit; Alexa Fluor 488 goat anti-mouse IgG1, and Alexa Fluor
555 goat anti-anti mouse IgG2a; all at 1:250) in 0.05% saponin in PBS
for 1 h at RT. After 3 washes with PBS, nuclei were stained with DAPI
(1:1000).
Fluorescence was visualized using a Leica DMRA2 ﬂuorescence mi-
croscope (Wetzlar, Germany) and images were recorded using a digital
Hamamatsu CCD camera (Hamamatsu City-Japan).
2.8. Flow cytometry analysis
Expression of lineage-speciﬁc markers during mesoderm (CD34)
or endoderm (CXCR4 and CD117) differentiation, respectively, was
determined by ﬂow cytometry. Brieﬂy, cells/EBs were collected, dis-
sociated with 0.25% Trypsin for 3 min at 37 °C. DMEM/10% FBS was
added, cells centrifuged at 200 g for 2 min and resuspended in
400 μL DMEM. Cells were then incubated with the respective anti-
bodies, CXCR4-APC (1:100, BD Pharmingen) and CD117 (c-Kit)-PE-
Cy7 (1:100, eBioscience), or CD34-APC (1:100; Invitrogen), for
60 min on ice, washed, and resuspended in 400 μl DMEM/10% FBS.
Stained cells were run on a FACS Canto II (BD Biosciences) and ana-
lyzed with FlowJo software program (TriStar).
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